+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Candidiasis"

From
Infectious Disease Diagnostic Market - Global Forecast 2026-2032 - Product Thumbnail Image

Infectious Disease Diagnostic Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Emerging Infectious Disease Diagnostics Market Report 2025 - Product Thumbnail Image

Emerging Infectious Disease Diagnostics Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Candida Infection Testing Market Report 2025 - Product Thumbnail Image

Candida Infection Testing Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Polymerase Chain Reaction (PCR) Market Report 2025 - Product Thumbnail Image

Polymerase Chain Reaction (PCR) Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Candidiasis is a type of fungal infection caused by the yeast Candida. It is the most common type of fungal infection in humans, and can affect the skin, mucous membranes, and other organs. Infectious disease testing is used to diagnose candidiasis, and can involve culturing the organism, antigen detection, or molecular testing. Treatment typically involves antifungal medications, and in some cases, surgery. The candidiasis market within the context of infectious disease testing is a growing field, with a range of products available to diagnose and treat the condition. Diagnostic tests include antigen detection, molecular testing, and culturing, while treatments include antifungal medications and, in some cases, surgery. Companies in the candidiasis market include Abbott, Becton Dickinson, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more